PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
Clinical trial NCT04493619 · TERMINATED
Trial details
- NCT number
- NCT04493619
- Sponsor
- Opna Bio LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2022-04-25
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.